Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Advanced solid malignancy or non-Hodgkin's lymphoma that is refractory to treatment or has recurred
Age > 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is testing a new cancer drug to see if it is safe and effective.
Who is the study for?
Adults over 18 with advanced solid tumors or non-Hodgkin's lymphoma that no longer respond to treatment can join. They must have good blood, kidney, and liver function, not be pregnant or breastfeeding, use effective contraception, and cannot have untreated brain metastases or significant heart issues.Check my eligibility
What is being tested?
The trial is testing AQ4N given once a week for three weeks in a four-week cycle. It aims to find the highest safe dose of AQ4N, understand its side effects, how it circulates in the body and if it effectively treats cancer.See study design
What are the potential side effects?
Potential side effects of AQ4N may include reactions at varying degrees affecting organs like the kidneys and liver due to toxicity levels as well as general symptoms such as fatigue or nausea related to chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cancer has come back or is not responding to treatment.
Select...
I am older than 18 years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
NovaceaLead Sponsor
10 Previous Clinical Trials
1,928 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have serious heart problems or uncontrolled high blood pressure.My blood, kidney, and liver tests are within normal ranges.My heart isn't working well.My cancer has come back or is not responding to treatment.I haven't had chemotherapy or radiation in the last 4 weeks.My brain scans show no tumor growth or swelling, and I don't need steroids.I am older than 18 years.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has this therapeutic option been authorized by the FDA?
"Our team at Power ranks the safety of this treatment as a 1, which reflects its status as an early-phase trial with limited data on efficacy and safety."
Answered by AI
Are there any vacancies available to join this research study?
"Reportedly, enrollment for this clinical trial is not open at this moment in time. This medical experiment was initially posted on August 1st 2004 and its information was recently updated on October 31st 2006. Despite being closed to recruitment, there are still 4000 other active studies looking for patients presently."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger